000			02201 a2200565 4500
005			20250514020439.0
264		0	_c20020402
008			200204s 0 0 eng d
022			_a0007-1188
024	7		_a10.1038/sj.bjp.0704423 _2doi
040			_aNLM _beng _cNLM
100	1		_aWalch, L
245	0	0	_aProstanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins. _h[electronic resource]
260			_bBritish journal of pharmacology _cDec 2001
300			_a1671-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid _xpharmacology
650	0	4	_aBiphenyl Compounds _xpharmacology
650	0	4	_aCarbazoles _xpharmacology
650	0	4	_aCulture Techniques
650	0	4	_aDibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide _xpharmacology
650	0	4	_aDinoprostone _xanalogs & derivatives
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEndothelium, Vascular _xphysiology
650	0	4	_aFemale
650	0	4	_aHeptanoic Acids _xpharmacology
650	0	4	_aHumans
650	0	4	_aIloprost _xpharmacology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMuscle Contraction _xdrug effects
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aProstaglandin Antagonists _xpharmacology
650	0	4	_aProstaglandins F, Synthetic _xpharmacology
650	0	4	_aPulmonary Veins _xdrug effects
650	0	4	_aReceptors, Prostaglandin _xphysiology
650	0	4	_aReceptors, Prostaglandin E _xagonists
650	0	4	_aReceptors, Prostaglandin E, EP1 Subtype
650	0	4	_aReceptors, Prostaglandin E, EP3 Subtype
650	0	4	_aReceptors, Thromboxane _xantagonists & inhibitors
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aVasoconstriction _xdrug effects
650	0	4	_aXanthenes _xpharmacology
650	0	4	_aXanthones
700	1		_ade Montpreville, V
700	1		_aBrink, C
700	1		_aNorel, X
773	0		_tBritish journal of pharmacology _gvol. 134 _gno. 8 _gp. 1671-8
856	4	0	_uhttps://doi.org/10.1038/sj.bjp.0704423 _zAvailable from publisher's website
999			_c11652560 _d11652560